Atlas Compliance Blog

Latest insights and updates from Atlas Compliance

Why NIS2 is Still Hard for Companies, Even with Automation Tools
September 8, 2025

Why NIS2 is Still Hard for Companies, Even with Automation Tools

tl;dr: NIS2 was made to make Europe safer on the internet; however, many firms still find it hard to meet the rules. The reasons include wide scope, differences between countries, unclear local rules, legacy systems, staff gaps, and complex supply chains. Automation helps, yet it cannot fix weak policies, unclear responsibilities, or poor data. Below […]

Read More
Do warning letters impact pharma stock investments?
September 5, 2025

Do warning letters impact pharma stock investments?

tl;dr: Yes, warning letters and multiple inspections affect pharma stocks. They create risks like production disruption, export bans, recalls, legal costs, reputation loss, and delayed approvals. In recent years, big pharma companies have received warning letters that moved markets. Before investing, always check a company’s inspection history, warning-letter responses, recall records, and remediation plans. What […]

Read More
How Does the FDA’s Drug Supply Chain Security Act Affect Your Business?​
September 3, 2025

How Does the FDA’s Drug Supply Chain Security Act Affect Your Business?​

tl;dr: The FDA’s DSCSA ensures prescription drugs in the U.S. are traceable to prevent counterfeit or unsafe products. By 2025, all manufacturers, distributors, and most pharmacies must comply with serialization, verification, and tracing requirements. Businesses can use tools like Atlas Compliance to simplify compliance and protect the supply chain. The Drug Supply Chain Security Act […]

Read More
Why Are QA Teams Choosing Atlas AI Copilot in 2025?
September 3, 2025

Why Are QA Teams Choosing Atlas AI Copilot in 2025?

tl;dr: In 2025, inspections are tougher and often unannounced. Atlas AI Copilot helps QA teams see what each inspector focuses on, their common observations, and gives a step-by-step prep guide—so teams stay ready and avoid surprises. If you work in pharma or biologics, 2025 feels like the year inspections got real again. FDA is inspecting […]

Read More
Change Control Basics for Smoother Project Management
July 18, 2025

Change Control Basics for Smoother Project Management

Changes in a project vary in nature. Some are unexpected, such as weather delays or illness, while others are formally requested. Regardless of how they arise, each change must be carefully evaluated and either accepted or rejected. Once a change is approved, it initiates a structured change control process to help ensure the project stays […]

Read More
CAPA Programs: How to Implement Them for Better Results
July 18, 2025

CAPA Programs: How to Implement Them for Better Results

Regulations in pharmaceuticals, life sciences, and biotech demand unwavering compliance and a focus on continuous quality improvement. One of the most persistent challenges faced by Quality Assurance and Regulatory Affairs professionals is implementing a truly effective CAPA (Corrective and Preventive Action) program. While the concept of a CAPA program is widely recognized as essential for […]

Read More
Corrective Action Requests Made Easy: A Step-by-Step Walkthrough
July 18, 2025

Corrective Action Requests Made Easy: A Step-by-Step Walkthrough

When a defect or nonconformity arises in a product, it can disrupt supply chains, impact customer trust, and lead to significant operational delays. One of the key challenges businesses face is not just identifying these issues, but ensuring they are resolved at the root level and prevented from recurring. This is where a Corrective Action […]

Read More